Changping Wu
About
In The Last Decade
Changping Wu
77 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.6k
- Molecular Biology 1.2k
- Immunology 1.0k
- Cancer Research 820
- Pulmonary and Respiratory Medicine 598
Countries citing papers authored by Changping Wu
This map shows the geographic impact of Changping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changping Wu more than expected).
Fields of papers citing papers by Changping Wu
This network shows the impact of papers produced by Changping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changping Wu. The network helps show where Changping Wu may publish in the future.
Co-authorship network of co-authors of Changping Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Changping Wu. A scholar is included among the top collaborators of Changping Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changping Wu. Changping Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA breakdown → | 123 |
| 2 | 4 | |
| 3 | A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling breakdown → | 425 |
| 4 | 16 | |
| 5 | 81 | |
| 6 | 33 | |
| 7 | 6 | |
| 8 | Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis. | 5 |
| 9 | 1 | |
| 10 | 23 | |
| 11 | 98 | |
| 12 | 10 | |
| 13 | 27 | |
| 14 | 2 | |
| 15 | 27 | |
| 16 | 30 | |
| 17 | 12 | |
| 18 | 69 | |
| 19 | 9 | |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.